维罗纳制药(VRNA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

VRNA 维罗纳制药

交易中 07-11 12:34:04 EDT

104.85

+0.00

+0.00%

最高104.93	最低104.80	成交量801.19万
今开104.87	昨收104.85	日振幅0.12%
总市值89.26亿	流通市值65.90亿	总股本8,513万
成交额8.40亿	换手率12.75%	流通股本6,285万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"VRNA","market":"US","secType":"STK","nameCN":"维罗纳制药","latestPrice":104.845,"timestamp":1752251638310,"preClose":104.85,"halted":0,"volume":8011945,"delay":0,"floatShares":62852600,"shares":85132002,"eps":-2.017734,"marketStatus":"交易中","change":-0.005,"latestTime":"07-11 12:34:04 EDT","open":104.87,"high":104.9293,"low":104.8,"amount":840073905.2626001,"amplitude":0.001233,"askPrice":104.85,"askSize":605,"bidPrice":104.84,"bidSize":7511,"shortable":3,"etf":0,"ttmEps":-2.017734,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1752264000000},"marketStatusCode":2,"adr":1,"adrRate":8,"listingDate":1493265600000,"exchange":"NASDAQ","adjPreClose":104.85,"preHourTrading":{"tag":"盘前","latestPrice":104.85,"preClose":104.85,"latestTime":"09:29 EDT","volume":1032,"amount":108153.61032,"timestamp":1752240570067},"postHourTrading":{"tag":"盘后","latestPrice":104.71,"preClose":104.85,"latestTime":"19:53 EDT","volume":87435,"amount":9167379.399,"timestamp":1752191580938},"volumeRatio":1.004641,"impliedVol":0.0704,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/VRNA","defaultTab":"news","newsList":[{"id":"2550426666","title":"默克公司拟100亿美元收购维罗纳制药，斩获COPD明星药","url":"https://stock-news.laohu8.com/highlight/detail?id=2550426666","media":"药事纵横","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550426666?lang=zh_cn&edition=full","pubTime":"2025-07-10 06:02","pubTimestamp":1752098575,"startTime":"0","endTime":"0","summary":"7月9日，默克公司宣布将以每股美国存托股票107美元的价格，总计约100亿美元收购维罗纳制药。通过此次交易，默克将获得维罗纳制药旗下治疗慢性阻塞性肺病的药物Ohtuvayre。Ohtuvayre获批用于成人慢性阻塞性肺疾病的维持治疗。温瑞维尔是一种激活素信号抑制剂，默克公司于2021年以115亿美元收购Acceleron制药公司时将其收入囊中。此次交易已获双方董事会一致批准，预计将于第四季度完成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710060531a6a01914&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710060531a6a01914&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0203345920.USD","IE0009355771.USD","LU0320765489.SGD","LU1989772840.SGD","LU1291159041.SGD","IE00BSNM7G36.USD","LU0265550946.USD","IE000M9KFDE8.USD","IE00BJJMRZ35.SGD","LU0965509010.AUD","LU1069347547.HKD","LU1989772923.USD","LU2023250843.SGD","LU0238689110.USD","LU0965509283.SGD","VRNA","IE00BFTCPJ56.SGD","LU0098860793.USD","LU0058720904.USD","LU1934455863.HKD","LU1917777945.USD","LU1037948541.HKD","BK4533","LU0266013472.USD","BK4550","LU0122379950.USD","LU2023250504.SGD","LU1057294990.SGD","LU1116320901.HKD","LU1066051498.USD","SG9999001440.SGD","SG9999013999.USD","LU0208291251.USD","LU2324357040.USD","IE00BBT3K403.USD","LU0070302665.USD","BK4007","SG9999014567.USD","SG9999015341.SGD","LU0106261372.USD","LU1116320737.USD","LU0211331839.USD","LU2361045086.USD","SG9999001176.SGD","MRK","LU2361044949.HKD","SG9999002232.USD","SGXZ57979304.SGD","LU1093756168.USD","LU0289739699.SGD"],"gpt_icon":0},{"id":"2550639900","title":"维罗纳制药美股盘前涨超20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550639900","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550639900?lang=zh_cn&edition=full","pubTime":"2025-07-09 18:46","pubTimestamp":1752057995,"startTime":"0","endTime":"0","summary":"维罗纳制药美股盘前涨超20%","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202507093452310378.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4007","VRNA"],"gpt_icon":0},{"id":"1129222845","title":"默沙东同意以107美元/ADS的价格收购维罗纳制药，总交易价值约100亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1129222845","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1129222845?lang=zh_cn&edition=full","pubTime":"2025-07-09 18:38","pubTimestamp":1752057507,"startTime":"0","endTime":"0","summary":"7月9日，$默沙东(MRK)$和专注于呼吸系统疾病的生物制药公司$维罗纳制药(VRNA)$公司今天宣布，两家公司已达成最终协议，根据该协议，默沙东将通过其子公司以每股美国存托股票 (ADS)107美元的价格收购维罗纳制药，每股美国存托股票代表8股维罗纳制药普通股，总交易价值约为100亿美元。","market":"us","thumbnail":"https://static.tigerbbs.com/e68f18a297e419bae3cc0320b6d8ff4e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/e68f18a297e419bae3cc0320b6d8ff4e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"默沙东同意以107美元/ADS的价格收购维罗纳制药，总交易价值约100亿美元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJT1NW94.SGD","LU0006306889.USD","LU0265550359.USD","LU1057294990.SGD","BK4550","BK4559","LU1093756325.SGD","LU1037948897.HKD","BK4588","LU1093756168.USD","MRK","LU0965508806.USD","LU1066051498.USD","IE00BLSP4239.USD","LU1037948541.HKD","VRNA","LU0289739699.SGD","LU0965509283.SGD","LU1571399168.USD","LU1066053197.SGD"],"gpt_icon":0},{"id":"1192625853","title":"维罗纳制药短线拉升涨超18%，默沙东接近达成以100亿美元的价格将其收购","url":"https://stock-news.laohu8.com/highlight/detail?id=1192625853","media":"老虎资讯综合","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1192625853?lang=zh_cn&edition=full","pubTime":"2025-07-09 13:26","pubTimestamp":1752038807,"startTime":"0","endTime":"0","summary":"7月9日（周三），维罗纳制药短线拉升涨超18%，默沙东接近达成以100亿美元的价格将其收购。","market":"us","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VRNA"],"gpt_icon":0},{"id":"1154297258","title":"默沙东据报接近以约100亿美元收购维罗纳制药","url":"https://stock-news.laohu8.com/highlight/detail?id=1154297258","media":"老虎资讯综合","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1154297258?lang=zh_cn&edition=full","pubTime":"2025-07-09 13:25","pubTimestamp":1752038719,"startTime":"0","endTime":"0","summary":"据英国《金融时报》周三报道， $默沙东(MRK)$ (Merck,)正接近达成一项价值约100亿美元的交易，收购专注于肺部疾病的生物技术公司 $维罗纳制药(VRNA)$ （Verona Pharma）。报道援引三位知情人士消息称，默沙东将为Verona的每股美国存托股份(ADS)支付107美元。受消息影响，维罗纳制药夜盘升18%。","market":"hk","thumbnail":"https://static.tigerbbs.com/df4ec61541b268a5353585001973d7cb","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/df4ec61541b268a5353585001973d7cb"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"默沙东据报接近以约100亿美元收购维罗纳制药","news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRK","VRNA"],"gpt_icon":0},{"id":"2550871502","title":"【维罗纳制药美股夜盘短线拉升超16%】呼吸系统药物制造商维罗纳制药美股夜盘短线拉升超16%，报道称默沙东接近达成以100亿美元的价格将其收购。","url":"https://stock-news.laohu8.com/highlight/detail?id=2550871502","media":"金融界","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550871502?lang=zh_cn&edition=full","pubTime":"2025-07-09 13:10","pubTimestamp":1752037830,"startTime":"0","endTime":"0","summary":"呼吸系统药物制造商维罗纳制药美股夜盘短线拉升超16%，报道称默沙东接近达成以100亿美元的价格将其收购。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/07/09131051580478.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU1941712348.USD","MRK","LU1983299246.USD","SG9999002232.USD","LU0006306889.USD","LU1116320737.USD","LU1162221912.USD","LU1934455863.HKD","LU1057294990.SGD","LU1093756168.USD","LU0208291251.USD","IE00BJJMRZ35.SGD","LU1066051498.USD","LU2023250504.SGD","LU0965509283.SGD","SG9999001440.SGD","SG9999001176.SGD","LU0238689110.USD","LU0265550946.USD","LU1917777945.USD","LU1585245621.USD","LU1291159041.SGD","LU0234572021.USD","IE00BJT1NW94.SGD","IE00B4R5TH58.HKD","LU0106261372.USD","LU0289739699.SGD","SG9999001176.USD","LU1934455194.USD","LU2089984988.USD","IE00BN8TJ469.HKD","SG9999002224.SGD","LU1989771016.USD","LU1699723380.USD","SG9999014559.SGD","BK4533","VRNA","LU1430594728.SGD","LU0211331839.USD","SGXZ57979304.SGD","LU0058720904.USD","BK4516","LU1989772840.SGD","LU2361044865.SGD","LU0265550359.USD","LU2361045086.USD","LU1037948541.HKD","LU1066053197.SGD","BK4588","LU0985320562.USD"],"gpt_icon":0},{"id":"2550578493","title":"维罗纳制药盘中异动 临近收盘股价大跌5.00%报86.64美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550578493","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550578493?lang=zh_cn&edition=full","pubTime":"2025-07-09 03:55","pubTimestamp":1752004521,"startTime":"0","endTime":"0","summary":"北京时间2025年07月09日03时55分，维罗纳制药股票出现波动，股价快速下跌5.00%。截至发稿，该股报86.64美元/股，成交量109.119万股，换手率1.28%，振幅5.44%。机构评级方面，在所有12家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。维罗纳制药股票所在的生物技术行业中，整体涨幅为0.76%。维罗纳制药公司简介：Verona Pharma PLC是一家临床阶段的生物制药公司，专注于开发和商业化治疗未满足医疗需求的呼吸系统疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709035521a43e9db2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709035521a43e9db2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VRNA","BK4007"],"gpt_icon":0},{"id":"2548886044","title":"维罗纳制药盘中异动 股价大跌5.03%报89.83美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548886044","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548886044?lang=zh_cn&edition=full","pubTime":"2025-07-02 00:34","pubTimestamp":1751387694,"startTime":"0","endTime":"0","summary":"北京时间2025年07月02日00时34分，维罗纳制药股票出现波动，股价快速下挫5.03%。截至发稿，该股报89.83美元/股，成交量79.5098万股，换手率0.93%，振幅7.87%。最近的财报数据显示，该股实现营业收入76.55百万美元，净利润-16.38百万美元，每股收益-0.19美元，毛利72.83百万美元，市盈率-45.01倍。机构评级方面，在所有12家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。维罗纳制药股票所在的生物技术行业中，整体涨幅为1.04%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507020034549532c7c6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507020034549532c7c6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","VRNA"],"gpt_icon":0},{"id":"2542533983","title":"维罗纳制药盘中异动 早盘急速上涨5.09%报91.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542533983","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542533983?lang=zh_cn&edition=full","pubTime":"2025-06-11 22:36","pubTimestamp":1749652598,"startTime":"0","endTime":"0","summary":"北京时间2025年06月11日22时36分，维罗纳制药股票出现异动，股价大幅上涨5.09%。截至发稿，该股报91.20美元/股，成交量50.3828万股，换手率0.59%，振幅3.72%。机构评级方面，在所有11家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。维罗纳制药股票所在的生物技术行业中，整体跌幅为0.01%。该信息摘要如下：坎托菲茨杰拉德公司：维持Verona Pharma评级，由增持调整至增持评级, 目标价由90.00美元调整至100.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611223639a703d1f3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611223639a703d1f3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","VRNA"],"gpt_icon":0},{"id":"2542538406","title":"坎托菲茨杰拉德公司：维持Verona Pharma评级，由增持调整至增持评级, 目标价由90.00美元调整至100.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2542538406","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542538406?lang=zh_cn&edition=full","pubTime":"2025-06-11 22:05","pubTimestamp":1749650753,"startTime":"0","endTime":"0","summary":"坎托菲茨杰拉德公司：维持Verona Pharma(VRNA.US)评级，由增持调整至增持评级, 目标价由90.00美元调整至100.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611221130977b1158&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611221130977b1158&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VRNA"],"gpt_icon":0},{"id":"2539293578","title":"维罗纳制药盘中异动 大幅拉升5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2539293578","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539293578?lang=zh_cn&edition=full","pubTime":"2025-05-30 03:26","pubTimestamp":1748546767,"startTime":"0","endTime":"0","summary":"北京时间2025年05月30日03时26分，维罗纳制药股票出现异动，股价急速上涨5.00%。截至发稿，该股报77.63美元/股，成交量108.089万股，换手率1.27%，振幅5.95%。机构评级方面，在所有11家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。维罗纳制药股票所在的生物技术行业中，整体涨幅为1.35%。维罗纳制药公司简介：Verona Pharma PLC是一家临床阶段的生物制药公司，专注于开发和商业化治疗未满足医疗需求的呼吸系统疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025053003260795073d71&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025053003260795073d71&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VRNA","BK4007"],"gpt_icon":0},{"id":"2534604434","title":"维罗纳制药盘中异动 早盘股价大跌5.00%报62.95美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2534604434","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534604434?lang=zh_cn&edition=full","pubTime":"2025-05-09 23:19","pubTimestamp":1746803972,"startTime":"0","endTime":"0","summary":"北京时间2025年05月09日23时19分，维罗纳制药股票出现波动，股价急速跳水5.00%。截至发稿，该股报62.95美元/股，成交量56.1555万股，换手率0.66%，振幅7.39%。最近的财报数据显示，该股实现营业收入76.55百万美元，净利润-16.38百万美元，每股收益-0.19美元，毛利72.83百万美元，市盈率-31.51倍。机构评级方面，在所有11家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。维罗纳制药股票所在的生物技术行业中，整体跌幅为0.22%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509231932a478546e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509231932a478546e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","VRNA"],"gpt_icon":0},{"id":"2532355159","title":"维罗纳制药2025财年第一财季实现净利润-16.38百万美元，同比增加36.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2532355159","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532355159?lang=zh_cn&edition=full","pubTime":"2025-05-04 00:00","pubTimestamp":1746288047,"startTime":"0","endTime":"0","summary":"5月4日，维罗纳制药公布财报，公告显示公司2025财年第一财季净利润为-16.38百万美元，同比增加36.46%；其中营业收入为76.55百万美元，每股基本收益为-0.19美元。从资产负债表来看，维罗纳制药总负债2.99亿美元，其中短期债务1.08百万美元，资产负债比为1.76，流动比率为0.09。机构评级：截至2025年5月4日，当前有11家机构对维罗纳制药目标价做出预测，其中目标均价为92.36美元，其中最低目标价为75.00美元，最高目标价为107.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250504000101a6d2261f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250504000101a6d2261f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VRNA"],"gpt_icon":0},{"id":"2532006807","title":"富国银行：维持Verona Pharma评级，由增持调整至增持评级, 目标价由93.00美元调整至107.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2532006807","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532006807?lang=zh_cn&edition=full","pubTime":"2025-05-01 00:15","pubTimestamp":1746029756,"startTime":"0","endTime":"0","summary":"富国银行：维持Verona Pharma(VRNA.US)评级，由增持调整至增持评级, 目标价由93.00美元调整至107.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050100180694e927a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050100180694e927a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VRNA"],"gpt_icon":0},{"id":"2530618769","title":"维罗纳制药盘中异动 快速上涨5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530618769","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530618769?lang=zh_cn&edition=full","pubTime":"2025-04-25 02:35","pubTimestamp":1745519717,"startTime":"0","endTime":"0","summary":"北京时间2025年04月25日02时35分，维罗纳制药股票出现波动，股价急速拉升5.13%。截至发稿，该股报66.56美元/股，成交量84.0272万股，换手率0.99%，振幅6.07%。机构评级方面，在所有10家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。维罗纳制药股票所在的生物技术行业中，整体涨幅为0.49%。维罗纳制药公司简介：Verona Pharma PLC是一家临床阶段的生物制药公司，专注于开发和商业化治疗未满足医疗需求的呼吸系统疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042502351794e1603e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042502351794e1603e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VRNA","BK4007"],"gpt_icon":0},{"id":"2529398736","title":"维罗纳制药盘中异动 股价大涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529398736","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529398736?lang=zh_cn&edition=full","pubTime":"2025-04-23 22:33","pubTimestamp":1745418804,"startTime":"0","endTime":"0","summary":"北京时间2025年04月23日22时33分，维罗纳制药股票出现波动，股价快速拉升5.01%。截至发稿，该股报65.12美元/股，成交量23.5337万股，换手率0.28%，振幅3.74%。机构评级方面，在所有10家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。维罗纳制药股票所在的生物技术行业中，整体涨幅为1.55%。维罗纳制药公司简介：Verona Pharma PLC是一家临床阶段的生物制药公司，专注于开发和商业化治疗未满足医疗需求的呼吸系统疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423223325aa2c790f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423223325aa2c790f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VRNA","BK4007"],"gpt_icon":0},{"id":"2526561380","title":"维罗纳制药盘中异动 股价大涨5.01%报56.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2526561380","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2526561380?lang=zh_cn&edition=full","pubTime":"2025-04-12 00:36","pubTimestamp":1744389370,"startTime":"0","endTime":"0","summary":"北京时间2025年04月12日00时36分，维罗纳制药股票出现波动，股价大幅拉升5.01%。截至发稿，该股报56.63美元/股，成交量35.5977万股，换手率0.42%，振幅5.47%。最近的财报数据显示，该股实现营业收入42.30百万美元，净利润-1.73亿美元，每股收益-2.13美元，毛利38.66百万美元，市盈率-26.20倍。机构评级方面，在所有9家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。维罗纳制药股票所在的生物技术行业中，整体涨幅为1.09%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250412003610aa2c6cf0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250412003610aa2c6cf0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","VRNA"],"gpt_icon":0},{"id":"2518270202","title":"维罗纳制药盘中异动 股价大跌5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518270202","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518270202?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:00","pubTimestamp":1741615203,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时00分，维罗纳制药股票出现异动，股价急速下挫5.10%。截至发稿，该股报61.35美元/股，成交量18.6847万股，换手率0.22%，振幅5.01%。机构评级方面，在所有9家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。维罗纳制药股票所在的生物技术行业中，整体涨幅为0.04%。维罗纳制药公司简介：Verona Pharma PLC是一家临床阶段的生物制药公司，专注于开发和商业化治疗未满足医疗需求的呼吸系统疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031022000398a2a46c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031022000398a2a46c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VRNA","BK4007"],"gpt_icon":0},{"id":"2517616769","title":"维罗纳制药2024财年实现净利润-1.73亿美元，同比减少216.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517616769","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517616769?lang=zh_cn&edition=full","pubTime":"2025-03-07 00:00","pubTimestamp":1741276856,"startTime":"0","endTime":"0","summary":"3月7日，维罗纳制药公布财报，公告显示公司2024财年净利润为-1.73亿美元，同比减少216.97%；其中营业收入为42.30百万美元，每股基本收益为-2.13美元。从资产负债表来看，维罗纳制药总负债2.70亿美元，其中短期债务1.12百万美元，资产负债比为1.76，流动比率为0.11。机构评级：截至2025年3月7日，当前有9家机构对维罗纳制药目标价做出预测，其中目标均价为80.33美元，其中最低目标价为72.00美元，最高目标价为93.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307000116abeb8d03&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307000116abeb8d03&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VRNA"],"gpt_icon":0},{"id":"2516663450","title":"维罗纳制药盘中异动 下午盘急速跳水5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516663450","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516663450?lang=zh_cn&edition=full","pubTime":"2025-03-04 04:28","pubTimestamp":1741033720,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日04时28分，维罗纳制药股票出现波动，股价急速下跌5.04%。截至发稿，该股报66.12美元/股，成交量93.7822万股，换手率1.10%，振幅5.97%。机构评级方面，在所有9家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。维罗纳制药股票所在的生物技术行业中，整体跌幅为0.03%。维罗纳制药公司简介：Verona Pharma PLC是一家临床阶段的生物制药公司，专注于开发和商业化治疗未满足医疗需求的呼吸系统疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304042841a25da2e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304042841a25da2e1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","VRNA"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.veronapharma.com","stockEarnings":[{"period":"1week","weight":0.1455},{"period":"1month","weight":0.2082},{"period":"3month","weight":0.8168},{"period":"6month","weight":1.3197},{"period":"1year","weight":4.8477},{"period":"ytd","weight":1.2578}],"compareEarnings":[{"period":"1week","weight":0.0008},{"period":"1month","weight":0.0377},{"period":"3month","weight":0.1721},{"period":"6month","weight":0.0781},{"period":"1year","weight":0.1149},{"period":"ytd","weight":0.0678}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"维罗纳制药公司根据英格兰及威尔士的法律以Isis Resources plc为名于2005年2月24日注册成立。2006年9月，该公司收购了在加拿大注册成立的私人公司Rhinopharma Limited，并更名为维罗纳制药公司。该公司是一家临床阶段的生物制药公司，专注于开发和商业化创新治疗方法，用于治疗具有显著未满足的医疗需求的呼吸系统疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.375,"avgChangeRate":-0.042371},{"month":2,"riseRate":0.5,"avgChangeRate":0.048229},{"month":3,"riseRate":0.25,"avgChangeRate":-0.023426},{"month":4,"riseRate":0.375,"avgChangeRate":-0.038912},{"month":5,"riseRate":0.555556,"avgChangeRate":-0.009341},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.015219},{"month":7,"riseRate":0.666667,"avgChangeRate":0.136865},{"month":8,"riseRate":0.5,"avgChangeRate":0.11834},{"month":9,"riseRate":0.375,"avgChangeRate":0.007343},{"month":10,"riseRate":0.25,"avgChangeRate":-0.009258},{"month":11,"riseRate":0.375,"avgChangeRate":0.006476},{"month":12,"riseRate":0.75,"avgChangeRate":0.295436}],"exchange":"NASDAQ","name":"维罗纳制药","nameEN":"Verona Pharma plc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"维罗纳制药(VRNA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供维罗纳制药(VRNA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"维罗纳制药,VRNA,维罗纳制药股票,维罗纳制药股票老虎,维罗纳制药股票老虎国际,维罗纳制药行情,维罗纳制药股票行情,维罗纳制药股价,维罗纳制药股市,维罗纳制药股票价格,维罗纳制药股票交易,维罗纳制药股票购买,维罗纳制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"维罗纳制药(VRNA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供维罗纳制药(VRNA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}